Analyzes and evaluates active transdermal products and assesses the market potential for existing and probable future products
Analyzes product designs, technologies and market development issues
Provides detailed descriptions of transdermal delivery market segments, market demographics, and business strategies
Charts product sales data, market share, and forecasts to 2015
Profiles active transdermal delivery companies, their product development activities, business strategies, and corporate alliances and affiliations
Assesses the importance of pharma-device alliances and design partnerships on future active transdermal products
Evaluates the impact of economic, technology, and regulatory factors on transdermal drug delivery markets.